AEON Biopharma, Inc. — 3 Filings
18 3 filings on record
This page lists all 3 filings submitted to the SEC by AEON Biopharma, Inc. (AEON), sorted by most recent first. Each row links to the full filing on EdgarLookup. AEON Biopharma, Inc. has filed 18 3 documents with the SEC since 2020. To view all SEC filings by AEON Biopharma, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
25
25-NSE
3
4
4/A
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
ARS/A
CERT
CORRESP
DEF 14A
DEFA14A
DEFM14A
DEFR14A
DEL AM
DRS
EFFECT
NT 10-Q
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-4
S-4/A
S-4MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 3 | — | 0001213900-26-009803 | Jan 29, 2026 | Jan 21, 2026 |
| 3 | — | 0001610717-25-000110 | May 1, 2025 | Apr 29, 2025 |
| 3 | OWNERSHIP DOCUMENT | 0001104659-24-065211 | May 24, 2024 | May 17, 2024 |
| 3 | OWNERSHIP DOCUMENT | 0001104659-24-048952 | Apr 18, 2024 | Apr 12, 2024 |
| 3 | FORM 3 | 0001477932-23-005637 | Jul 31, 2023 | Jul 21, 2023 |
| 3 | — | 0001213900-23-060425 | Jul 28, 2023 | Jul 21, 2023 |
| 3 | OWNERSHIP DOCUMENT | 0001104659-23-083564 | Jul 24, 2023 | Jul 21, 2023 |
| 3 | OWNERSHIP DOCUMENT | 0001104659-23-083563 | Jul 24, 2023 | Jul 21, 2023 |
| 3 | OWNERSHIP DOCUMENT | 0001104659-23-083562 | Jul 24, 2023 | Jul 21, 2023 |
| 3 | OWNERSHIP DOCUMENT | 0001104659-23-083561 | Jul 24, 2023 | Jul 21, 2023 |
| 3 | OWNERSHIP DOCUMENT | 0001104659-23-083560 | Jul 24, 2023 | Jul 21, 2023 |
| 3 | OWNERSHIP DOCUMENT | 0001104659-23-083559 | Jul 24, 2023 | Jul 21, 2023 |
| 3 | OWNERSHIP DOCUMENT | 0001104659-23-083555 | Jul 24, 2023 | Jul 21, 2023 |
| 3 | OWNERSHIP DOCUMENT | 0001104659-21-016227 | Feb 8, 2021 | — |
| 3 | OWNERSHIP DOCUMENT | 0001104659-21-016225 | Feb 8, 2021 | — |
| 3 | OWNERSHIP DOCUMENT | 0001104659-21-016224 | Feb 8, 2021 | — |
| 3 | OWNERSHIP DOCUMENT | 0001104659-21-016223 | Feb 8, 2021 | — |
| 3 | OWNERSHIP DOCUMENT | 0001104659-21-016222 | Feb 8, 2021 | — |